Bio-Gate AG Stock
Bio-Gate AG Stock
Heavy losses for Bio-Gate AG today as the stock fell by -€0.035 (-6.540%).
For the coming years our community has positive and negative things to say abot the Bio-Gate AG stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Non-cyclic/Cyclic" there were negative voices in the community.
Pros and Cons of Bio-Gate AG in the next few years
Pros
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Gate AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Gate AG | -6.540% | -17.355% | -9.910% | -50.000% | -37.500% | -64.286% | -89.583% |
| Alpha Pro Tech Ltd. | 0.000% | -4.018% | -6.114% | 6.436% | 16.848% | 22.857% | -44.659% |
| Eifelhoehen-Klinik | 0.000% | 0.000% | 7.692% | 193.706% | 68.000% | 100.000% | 14.130% |
| Maternus-Kliniken AG | -0.530% | 9.884% | 2.717% | -25.000% | 1.613% | -53.218% | -77.174% |
News
EQS-Adhoc: Bio-Gate AG: Resolves to Conduct a Capital Increase from Authorized Capital and Announces the Terms of the Rights Offering Approved by the Annual General Meeting on June 30, 2026
EQS-Adhoc: Bio-Gate AG: Resolves to Conduct a Capital Increase from Authorized Capital and Announces the Terms of the Rights Offering Approved by the Annual General Meeting on June 30, 2026
